Neurology

FDA Okays First Generic Naloxone Nasal Spray for Opioid Overdose

The FDA has granted final approval for the first generic naloxone hydrochloride nasal spray for reversing or stopping the effects from an opioid overdose.
FDA Approvals

Source link




Related posts

EFFECTS OF DRINKING ALCOHOL ON HEALTH

Newsemia

First Prevalence Data on Dementia in Sexual Minority Seniors

Newsemia

The added value of bedside examination and screening QST to improve neuropathic pain identification in patients with chronic pain.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy